Drug Development
Derma Sciences Announces Launch Plan for MOBILITY1(TM) Intermittent Compression Therapy Device
Published in Drug Law Weekly, September 16th, 2008
Derma Sciences, Inc. (BULLETIN BOARD: DSCI) announced that it will begin to sell its novel MOBILITY1(TM) Intermittent Pneumatic Compression Therapy device beginning in October after initially introducing the product to vascular surgeons at the 9th Annual New Cardiovascular Horizons (NCVH) Conference, scheduled September 10-13, 2008 in New Orleans. The patented device, licensed from Israeli technology company C-Boot in December 2006, is indicated for the treatment of chronic venous insufficiency, venous leg ulcers, lymphadema, the prevention of deep vein thrombosis, and numerous other indications. The product will be the only one of its kind, allowing mobile patients to receive optimal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-09-16)
More Articles from Drug Law Weekly
- Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals Completes Second Closing of Senior Convertible Debt Financing - Alpharma Inc.
Alpharma Adopts Limited Duration Shareholder Rights Plan - Alzheimer Disease
Anavex completes successful preclinical studies on lead Alzheimers drug candidate - Alzheimer Disease
Pfizer and Medivation Enter Into Global Agreement To Co-develop and Market Dimebon for the Treatment of Alzheimers and Huntingtons Diseases - American Academy of Ophthalmology
Use of Electronic Health Records by Eye M.D.s; Two Studies Refine Risks and Predictors for Advanced Macular Degeneration - ASARCO LLC
ASARCO LLC Wins Liability Phase of Fraudulent Transfer Trial against Grupo Mexico - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
